Table 3 Multivariable adjusted predictors of events (n = 3058)
MAC/MIC/HF/Death OR (95% CI) | MAC* OR (95% CI) | MIC* OR (95% CI) | HF OR (95% CI) | |
|---|---|---|---|---|
Patient characteristics at baseline | ||||
Age ≥ median | 1.36 (1.10–1.68) | 1.15 (0.71–1.86) | 1.15 (0.89–1.47) | 2.25 (1.21–4.16) |
Male vs. female | 1.17 (0.96–1.43) | 1.36 (0.87–2.14) | 1.21 (0.96–1.54) | 0.74 (0.45–1.20) |
BMI ≥ median | 1.01 (0.83–1.23) | 0.69 (0.45–1.07) | 1.11 (0.87–1.41) | 0.85 (0.52–1.38) |
Diabetes duration ≥ median | 1.29 (1.06–1.57) | 1.94 (1.24–3.05) | 1.33 (1.05–1.68) | 0.91 (0.56–1.48) |
Laboratory values | ||||
HbA1c ≥ median | 1.12 (0.90–1.39) | 0.92 (0.57–1.46) | 1.29 (1.00–1.66) | 1.14 (0.66–1.96) |
FPG ≥ median | 1.09 (0.89–1.35) | 1.00 (0.63–1.59) | 1.18 (0.92–.51) | 0.60 (0.34–1.04) |
Complications | ||||
Vascular disease* | 1.73 (1.39–2.16) | 2.72 (1.72–4.31) | 1.58 (1.22–2.06) | 1.14 (0.66–1.96) |
HF | 2.78 (2.10–3.68) | 1.97 (1.13–3.43) | 1.53 (1.07–2.18) | -- |
Severe hypoglycaemia | 1.24 (0.59–2.62) | 0.44 (0.06–3.38) | 1.88 (0.85–4.14) | 1.27 (0.35–4.60) |